FilingFirehose · free AI preview
NewAmsterdam Pharma Co N.V.
NAMSW · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 2
Types: Officer Departure
NewAmsterdam Pharma (NAMSW) has filed two officer departure notices within the past 90 days (April and June 2026), both marked as Item 5.02 events. While the company shows no detected cyber incidents in our monitoring window, the consecutive leadership changes warrant closer examination of underlying business stability and governance continuity. The full $49 Report contextualizes these departures against 12-month SEC filings, calculates dilution risk from recent financing activity, and cross-references AI-detected stress signals in executive communications and capital structure changes.
Want the full 5-section $49 Report on NAMSW?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.